EMEA-000625-PIP01-09-M03 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Infectious diseases
PIP number: P/0325/2018
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Age-appropriate dosage form, other
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Maci - referral
matrix applied characterised autologous cultured chondrocytes
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Maci
matrix-applied characterised autologous cultured chondrocytes
Fractures, Cartilage
Date of authorisation:
Date of refusal:
Revision: 4
Last updated:
MedicineHumanExpired
Olysio
simeprevir
Hepatitis C, Chronic
Date of authorisation:
Revision: 13
Last updated:
MedicineHumanWithdrawn
EMEA-000979-PIP01-10-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0012/2018
Route(s) of administration: Implant use
Pharmaceutical form(s):
Implant
Decision date:
Last updated:
Compliance check: ✖
PIPHuman